Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS New Policy Statement for Catheter Ablation of AF
Author(s): Kenneth Ellenbogen Added: 1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best… View more

Electrophysiology & Arrhythmia
AHA 25: The OCEAN Trial
Author(s): Atul Verma Added: 6 months ago
AHA Scientific Sessions 2025 - Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). The prospective, open-label, randomised trial aimed to investigate ongoing oral anticoagulation with rivaroxaban 15 mg daily compared to antiplatelet therapy in patients with clinical stroke risk factors at least one year post-successful catheter… View more

Anticoagulation

Electrophysiology & Arrhythmia
EHRA 24: FIH Novel PFA Catheter for PVI
Author(s): Vivek Reddy Added: 2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more

Electrophysiology & Arrhythmia
EHRA 24: Ablation Strategies for Repeat Procedures in Recurrent AF
Author(s): Boris Schmidt Added: 2 years ago
EHRA 24 - Investigator, Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, DE) is interviewed on ablation strategies for repeat procedures in patients with recurrent atrial fibrillation (AF).The ASTRO trial is a multi-centre prospective randomized study that enrolled 256 patients with drug-refractory AF despite previous AF ablation. The trial showed no statistically significant differences… View more

Electrophysiology & Arrhythmia
THT 2025: GSN Ablation in HFpEF
Author(s): Marat Fudim Added: 1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more

Heart Failure
AHA 25: The PFA-SHAM Study
Author(s): Vivek Reddy Added: 6 months ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then… View more

Electrophysiology & Arrhythmia
AHA 25: The DARE-AF Trial
Author(s): Chao Jiang , Zhao Zixu Added: 6 months ago
AHA Scientific Sessions 2025 – Dr Chao Jiang and Dr Zhao Zixu (Beijing Anzhen Hospital, CN) discuss the findings from the DARE-AF (NCT06433479) randomized clinical trial, investigating whether dapagliflozin reduces atrial fibrillation burden following catheter ablation in patients without diabetes or heart failure.This single-center, open-label trial enrolled 200 patients with persistent atrial… View more

Electrophysiology & Arrhythmia
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia
Will PFA Redefine AF Ablation Strategies in 2026?
Author(s): Tina Baykaner , Added: 3 months ago
AF Symposium 2026 - Pulsed field ablation in atrial fibrillation: Will it Redefine AF Ablation Strategies?Arrhythmia Academy board member Dr Tina Baykaner (Stanford University, Stanford, CA, US) is joined by Dr Melanie Gunawardene (CCB Frankfurt und Main-Taunus, Frankfurt, DE) exploring whether pulsed field ablation will fundamentally transform atrial fibrillation ablation strategies in 2026.This… View more

Electrophysiology & Arrhythmia
AF Symposium 26: Redo AF Ablation: When to Go Beyond PVI?
Author(s): Boris Schmidt , Atul Verma Added: 3 months ago
AF Symposium 2026 - Repeat ablation strategies: Moving Beyond Pulmonary Vein Isolation and the Role of Advanced Mapping.Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, Frankfurt, DE) and Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) discuss optimal approaches to redo atrial fibrillation ablation and the critical decision of when to extend beyond… View more

Electrophysiology & Arrhythmia